Studies of small molecule interactions with protein phosphatases using biosensor technology.

Area of Science:

• Biochemistry
• Molecular Biology
• Pharmacology

Background:

• Protein phosphorylation by kinases and phosphatases regulates cellular signaling.
• Dysregulation of phosphatases is linked to various diseases.
• Phosphatases are key therapeutic targets.

Purpose of the Study:

• To develop a straightforward surface plasmon resonance (SPR) methodology for analyzing small molecule binding to phosphatases.
• To investigate immobilization conditions for serine/threonine phosphatases (PP1, PP2B) and tyrosine phosphatase (PTP1B).
• To evaluate inhibitor binding kinetics and specificity for phosphatase drug discovery.

Main Methods:

• Utilized surface plasmon resonance (SPR) technology for analyzing small molecule interactions.
• Optimized phosphatase immobilization using reducing conditions, inhibitors, and metal ions.
• Compared inhibitor binding kinetics to PP2B alone versus in complex with calmodulin.
• Assessed inhibitor specificity across different phosphatase targets.

Main Results:

• Demonstrated a novel SPR methodology for analyzing small molecule binding to PP1, PP2B, and PTP1B.
• Revealed distinct kinetic differences in inhibitor binding to PP2B with and without its regulatory subunit, calmodulin.
• Showcased the method's utility in testing inhibitor specificity and demonstrating inhibition of PP1-inhibitor-2 binding by a small molecule.

Conclusions:

• The developed SPR methodology provides valuable kinetic data for phosphatase inhibitor development.
• This approach aids in designing highly specific and high-affinity phosphatase inhibitors.
• Data on compound binding independent of enzyme activity is crucial for drug discovery.